Related Experiment Video
Updated: Jul 25, 2025

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting
Published on: September 25, 2012
Case Report: Brainstem angiocentric glioma presenting in a toddler child-diagnostic and therapeutic challenges
Zita Reisz1, Bence Laszlo Radics2, Peter Nemes3
1Department of Clinical Neuropathology, King's College Hospital, London, United Kingdom.
Insights
Brainstem angiocentric glioma (AG) is rare and difficult to treat. This case highlights diagnostic challenges and the need for targeted therapies for this rare brain tumor.
Area of Science:
- Pediatric neuro-oncology
- Neuro-oncology
- Brain tumor research
Background:
- Angiocentric gliomas (AG) in the brainstem are exceptionally rare.
- Brainstem AG can present diagnostic challenges and therapeutic uncertainties.
- This study details a rare case of brainstem AG in a toddler.
Abstract:
Introduction: Angiocentric gliomas (AG) in brainstem location are exceedingly rare and might cause differential diagnostic problems and uncertainty regarding the best therapeutic approach. Hereby, we describe the clinicopathological findings in a brainstem AG presenting in a toddler child and review the literature. Case report: A 2-year-old boy presented with 5 weeks history of gait disturbances, frequent falls, left-sided torticollis and swallowing problems. MRI head showed a T2-hyperintense, partly exophytic mass lesion centred in the pontomedullary region, raising the possibility of diffuse midline glioma. The exophytic component was partially resected by suboccipital craniotomy, leaving intact the infiltrative component. Ventriculoperitoneal shunt was implanted due to postoperative hydrocephalus. Histological examination revealed a moderately cellular tumour consisted of bland glial cells infiltrating the brain parenchyma and radially arranged around the blood vessels. By immunohistochemistry, the tumour strongly expressed S100 and GFAP in addition to intense nestin positivity, while OLIG2 was negative in the perivascular tumour cells. DNA methylation array profiled the tumour as "methylation class diffuse astrocytoma, MYB or MYBL1-altered subtype B (infratentorial)" and an in-frame MYB::QKI fusion was identified by RNA sequencing, confirming the diagnosis of angiocentric glioma. The patient has been initially treated with angiogenesis inhibitor and mTOR inhibitor, and now he is receiving palliative vinblastine. He is clinically stable on 9 months follow-up. Conclusion: Brainstem AG may cause a diagnostic problem, and the surgical and oncological management is challenging due to unresectability and lack of response to conventional chemo-radiation. In the future, genetically-tailored therapies might improve the prognosis.

